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Abstract: Selected species of cyanobacteria and green algae have been reported to produce lipophilic 
polymethoxy-1-alkenes (PMAs) which were shown to exhibit in vivo teratogenicity. Considering 
that information on PMAs in Arthospira sp. (known commercially as Spirulina) and Chlorella sp. 
cultivated for food supplement production was essentially lacking, the present study screened 
Chlorella (n = 10) and Spirulina (n = 13) food supplements registered in the European Union. Mass 
spectrometry analysis of column fractionated extracts was performed. None of the four variants 
previously reported in some cyanobacteria and green algae, nor any potentially related structures 
were detected in the studied samples. Since the isolated lipophilic fractions contained various 
compounds, they were further screened for in vivo teratogenicity in Danio rerio embryo, and for the 
potential to induce oxidative stress and genotoxicity in the liver and neurotoxicity in the brain of 
adult zebrafish. None of the tested food supplements had detectable levels of PMAs or any 
potentially related structures. No teratogenicity was revealed except for spinal curvature induced 
by fractions obtained from two Chlorella products. Selected fractions revealed cytotoxicity as 
indicated by an increased level of reactive oxygen species, catalase activity, lipid peroxidation and 
increased frequency of DNA strand breaks in hepatic tissue. The majority (60%) of Chlorella 
fractions induced an increase in cholinesterase activity in zebrafish brain homogenate while 
exposure to 61.5% of Spirulina fractions was associated with its decrease. The present study 
confirms that Chlorella and Spirulina food supplements are free of teratogenic PMAs, although the 
observed in vivo toxicities raise questions regarding the quality of selected products. 
Keywords: cyanotoxins; polymethoxy-1-alkenes; food supplements; Arthrospira; Spirulina; Chlorella; 
human health risk assessment; zebrafish teratogenicity; oxidative stress; genotoxicity; neurotoxicity 
Key Contribution: The commercial microalgal food supplements were not found to contain 
teratogenic polymethoxy-1-alkenes; although some in vivo toxicities were demonstrated in the case 
of selected lipophilic fractions obtained from these products. 
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1. Introduction 
There is increasing interest in microalgal food supplements and other microalgae-based 
foodstuffs. The majority of these are based on Chlorella sp. and Arthrospira sp. (sold under the 
commercial name of “spirulina”), with the greatest production in Asia, particularly in China [1]. As 
evidenced, these products can be a source of proteins, vitamins and selected macro- and micro-
elements, particularly iron [2–4]. A number of clinical trials on the therapeutic value of microalgal 
food supplements have been performed revealing their antihypertensive, antilipidemic, 
hypoglycemic and immunomodulatory effects [5–7]. 
Generally, the consumption of food supplements based on Chlorella or Arthrospira biomass has 
not been associated with health risks, and both are considered safe and are approved by food 
regulatory bodies such as the European Food Safety Agency (EFSA) or the Food and Drug 
Administration (FDA) [1]. However, over the years there have been some reports of an increased 
content of toxic metals, metalloids and cyanotoxins in selected commercial formulas which are 
attributed to the poor quality of production process (e.g., contaminated culture media, chemical 
methods of biomass harvesting, co-occurrence of toxigenic cyanobacteria species) [4,8–10]. The 
observed adverse effects mostly included mild gastrointestinal events such as diarrhea, nausea, 
abdominal cramps or vomiting [11,12]. 
Species belonging to the Arthrospira and Chlorella genera are not known to synthesize any toxic 
compounds that would cause human health risks. However, to our surprise and to the best of our 
knowledge, the presence of polymethoxy-1-alkenes (PMAs) in these supplements has never been 
subjected to study. PMAs are lipophilic compounds initially identified in cyanobacterium Tolypothrix 
conglutinate, and later shown to be present in various other freshwater microalgae, including 
cyanobacteria (Aphanizomenon ovalisporum, Raphidiopsis raciborskii, Anabaena sp., Nostoc sp., 
Microcystis sp., Pseudanabaena sp., Scytonema burmanicum, S. ocellatum, and S. mirabilum) and green 
algae (Pediastrum sp. and Scenedesmus sp.) [13–18]. As shown recently, the presence of PMAs may be 
strain-dependent or geographically diversified as no evidence was found for A. gracile or R. raciborskii 
isolated from lakes in Central Europe [19]. Overall, four PMAs varying in chain length have been 
identified to date (Figure 1). These compounds were also shown to reveal teratogenicity in a Danio 
rerio embryo experimental model [17,18]. However, the in vivo rodent models did not reveal any 
adverse effect of Chlorella or Spirulina supplementation on pregnancy outcome [20,21]; the use of 
the latter in pregnant women was shown by one study to correlate with oligohydramnios [22–24]. All 
in all, this highlights that exploring the presence of PMAs in commercially available microalgal 
supplements for human consumption is urgently needed. This is particularly important given the 
fact that these products are reported to be used by pregnant women [22], and some authors suggest 
that they may be beneficial during pregnancy and lactation as well as early childhood development 
due to their nutritional value [25,26]. 
Figure 1. The four polymethoxy-1-alkenes identified so far in selected cyanobacteria and green algae. 
In our previous research, we have successfully utilized nuclear magnetic resonance and mass 
spectrometry to screen PMA content in cyanobacteria A. gracile and R. raciborskii isolated from 
freshwater lakes in Poland. The mass spectrometry is however a method of choice as it is a much 
more sensitive and was utilized by more recent investigations [17–19]. The aim of this study was to 
investigate the PMA content in commercial Chlorella and Spirulina food supplements originating 
from cultivations in North America, Asia and Europe as well as to evaluate the toxicity of isolated 
lipophilic fractions using a zebrafish Danio rerio experimental model. The toxicological screening was 
performed because, beside PMAs, microalgae can produce a variety of different lipophilic toxic 
compounds, including teratogenic retinoic acids and carotenoid glycosides [27,28]. A set of assays 
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was employed to evaluate whether the isolated fractions of food supplements can cause 
teratogenicity in zebrafish embryos as well as induce oxidative stress and genotoxicity in the liver, 
genotoxicity in peripheral red blood cells and neurotoxicity in the brain of adult zebrafish. 
2. Results 
2.1. Identification of Polymethoxy-1-Alkenes in Food Supplements 
Ten commercially available Chlorella and thirteen Spirulina food supplements (Table 1) were 
screened for the content of PMAs using mass spectrometry following extraction of samples in CHCl3, 
drying under high vacuum and fractionation using silica gel chromatography eluting with a stepwise 
gradient of ethyl acetate in petrol (10%, 20%, 40% and 100%). Since no analytical standards were 
available and no database for PMAs exists, a comparison with literature reporting PMA detection 
using mass spectrometry was performed [17,18] in all of these fractions. The analysis was targeted 
towards the identification of known PMAs and also the presence of potential homologous 
compounds which contain extra [-CH=CH-]n, [-CH2CH(OMe)-]n or [-CH2CH2-]n fragments. None of 
these molecules were apparent in any studied Spirulina and Chlorella food supplement, and analysis 
of the major peaks did not correlate with these or any potentially related structures. 
Table 1. The general characteristics of studied Chlorella (n = 10) and Spirulina (n = 13) food 
supplements. 
Sample Code  Species Declared  on the Label Country of Origin Appearance 
Chlorella 
C1 Chlorella sp. China Tablets 
C2 Chlorella vulgaris Taiwan Tablets 
C3 Chlorella pyrenoidosa Japan Tablets 
C4 Chlorella sp. India Tablets 
C5 Chlorella sp. China Powder 
C6 Chlorella sp. China Powder 
C7 Chlorella pyrenoidosa China Powder 
C8 Chlorella vulgaris China Powder 
C9 Chlorella vulgaris Portugal Powder 
C10 Chlorella vulgaris China Tablets 
Spirulina 
 S1 Spirulina sp. China Powder 
 S2 Spirulina sp. China Powder 
 S3 Spirulina sp. China Powder 
 S4 Spirulina platensis China Powder 
 S5 Spirulina sp. Taiwan Powder 
 S6 Spirulina pacifica USA Tablets 
 S7 Arthrospira platensis China Powder 
 S8 Spirulina platensis China Tablets 
 S9 Spirulina sp. China Tablets 
 S10 Spirulina maxima China Tablets 
 S11 Spirulina sp. China Tablets 
 S12 Spirulina sp. China Tablets 
 S13 Spirulina sp. India Powder 
2.2. Toxicological Screening 
An extracted lipophilic fraction (100% ethyl acetate) of each Chlorella (C1–C10) and Spirulina 
(S1–S13) food supplement was used to test teratogenicity in zebrafish embryo, oxidative stress and 
genotoxicity in the liver of adult specimens, genotoxicity in peripheral red blood cells and 
neurotoxicity in the brain. 
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2.2.1. Evaluation of Teratogenicity of Lipophilic Fractions in Zebrafish Embryo 
All control zebrafish embryos (both in Tris-buffer and Tris-buffer + 0.19% ethanol) met the 
acceptance criteria of >90% survival rate and normal development during the 120 h of the experiment. 
The exposure to lipophilic fractions of Chlorella and Spirulina food supplements did not produce 
any observable effect on survival and fingerprint endpoints, with two exceptions: C1 and C9 in which 
the scoliosis was induced (Table 2; Table 3). This effect was, however, recorded only after 96 h of 
exposure. 
Table 2. The effect of lipophilic fractions (100% ethyl acetate) isolated from Chlorella food 




CTRL C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 
Coagulated eggs - - - - - - - - - - - 
Head malformation  - - - - - - - - - - - 
Eyes malformation  - - - - - - - - - - - 
Chorda malformation - - - - - - - - - - - 
Tail malformation  - - - - - - - - - - - 
Egg yolk malformation  - - - - - - - - - - - 
Growth retardation - - - - - - - - - - - 
Spinal curvature - - + - - - - - - + - 
CTRL, control; “-“, normal; “+”, abnormal (reflected in ≥50% of all embryos and/or larvae). 
Table 3. The effect of lipophilic fractions (100% ethyl acetate) isolated from Spirulina food 
supplements (S1–S13) on teratogenicity in zebrafish embryos (n = 6) exposed in a static manner for 
120 h. 
Developmental endpoint  
Sample 
CTRL S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12 S13 
Coagulated eggs - - - - - - - - - - - - - - 
Head malformation - - - - - - - - - - - - - - 
Eyes malformation - - - - - - - - - - - - - - 
Chorda malformation - - - - - - - - - - - - - - 
Tail malformation - - - - - - - - - - - - - - 
Egg yolk malformation - - - - - - - - - - - - - - 
Growth retardation - - - - - - - - - - - - - - 
Spinal curvature - - - - - - - - - - - - - - 
CTRL–control; “-“, normal; “+”, abnormal (reflected in ≥50% of all embryos and/or larvae). 
2.2.2. Oxidative Stress in Liver of Adult Zebrafish 
The liver tissue collected from adult D. rerio revealed increased levels of reactive oxygen species 
(ROS) and lipid peroxidation (as measured by the content of thiobarbituric acid reactive substances; 
TBARS) following the exposure of fish to 7/10 and 6/10 fractions of Chlorella supplements, 
respectively. In comparison, ROS and TBARS were elevated after exposure to 5/13 and 3/13 fractions 
of Spirulina supplements (Figure 2). Moreover, the exposure to S11-S13 fractions was associated with 
a decrease in TBARS levels as compared to control. ROS and TBARS were in a positive correlation (r 
= 0.44, p < 0.001). Catalase (CAT) activity in hepatic tissue varied from oppression following exposure 
to C5 and S4 fractions, to two-fold elevation after exposure to the S13 fraction (Figure 2). The majority 
of fractions had no effect on GST activity, except for C4, C9, S3 and S11 when its decrease was 
observed, and for S4 when an increase was recorded. CAT activity revealed a negative correlation 
with levels of ROS and TBARS (r = −0.22, p = 0.007 and r = −0.30, p = 0.001 correspondingly), whereas 
no significant correlation for glutathione S-transferase (GST) activity and ROS/TBARS was found (p 
> 0.05). 
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Figure 2. The effect (mean ± SD) of the lipophilic fraction (100% ethyl acetate) isolated from Chlorella 
(A,C,E,G) and Spirulina (B,D,F,H) food supplements on reactive oxygen species, lipid peroxidation 
(TBARS), catalase (CAT) and glutathione S-transferase (GST) activity in hepatic tissue of zebrafish (n 
= 6). Identical superscripts denote no significant differences between treatments (Dunn’s test after 
Kruskal–Wallis ANOVA, p > 0.05). CTRL–control. 
2.2.3. Geno and Neurotoxicity Signs in Adult Zebrafish 
Most of tested fractions did not induce DNA strand breaks (DNAsb) in zebrafish liver. Exposure 
to any Spirulina sample was associated with an increased frequency of micronucleated peripheral 
red blood cells (Figure 3). Moreover, most of the Chlorella and Spirulina fractions tested induced 
changes in cholinesterase activity in fish brain with both, a significant decrease (C3, S4, S6, S8–S13) 
and increase (C5–C10, S1–S3, S5) noted (Figure 3). 
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Figure 3. The effect (mean ± SD) of the lipophilic fraction (100% ethyl acetate) isolated from Chlorella 
(A,C,E) and Spirulina (B,D,E) food supplements on DNA strand breaks in hepatic tissue, micronuclei 
frequency in peripheral red blood cells and cholinesterase activity in the brain of zebrafish (n = 6). 
Identical superscripts denote no significant differences between treatments (Dunn’s test after 
Kruskal–Wallis ANOVA, p > 0.05). CTRL–control. 
3. Discussion 
As postulated, ensuring the safety of food supplements based on natural products requires the 
implementation of analytical screening and the application of toxicity testing [29,30]. In the United 
States and the European Union, the safety of these products remains the responsibility of the 
manufacturer, while safety assurance is mostly limited to post-marketing surveillance for adverse 
effects [31]. Regulations have, however, been developed to lessen the possibility of food supplements 
being contaminated with toxic metals, herbicides or pathogenic microorganisms [31]. Nonetheless 
not all compounds of potential concern can be subject to random screening. Microalgae are known to 
produce a wide array of bioactive metabolites, while the precise structures of selected ones remain 
yet to be elucidated [32–35]. 
Surprisingly, the content of PMAs, which were found for the first time in cyanobacteria in 1979 
[13] and were later proven to be teratogenic [17], has never been investigated for Chlorella or 
Spirulina food supplements. The broadest screening of these compounds in green algae and 
cyanobacteria, encompassing a total of 98 strains, was performed by Jaja-Chimedza et al. [18]. 
However, this study investigated only one isolate of Arthrospira sp. [18] while the production of 
bioactive metabolites in microalgae, including PMAs in cyanobacteria, has been shown to be 
geographically diversified and often strain-dependent [19,36]. Importantly, such strain-dependency 
in the production of various compounds, which are present only in small quantities in microalgal 
biomass, was also documented for strains belonging to the Arthrospira genus [37]. Moreover, one 
should note that even if PMAs were not produced by any strain of Chlorella and Arthrospira cultivated 
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for human consumption, the presence of these compounds in food supplements may potentially 
originate from culture contamination with other microalgal species. For example, the occurrence of 
hepatotoxic microcystins in selected food products based on Chlorella and Arthrospira biomass has 
been linked to the co-occurrence of toxigenic cyanobacteria such as Microcystis [38–42]. The present 
study rules out the presence of teratogenic PMAs or related structures in both Spirulina and Chlorella 
food supplements and can confirm consumer safety in this respect. 
Nevertheless, one should note that PMAs are not the only teratogenic compounds which could 
potentially be present in microalgal cells. For example, selected cyanobacteria and green-algae strains 
have been found to produce retinoic acids and carotenoid glycosides which triggered a diverse set of 
teratogenic effects in the Danio rerio experimental model [27,28,43]. No Arthrospira strains were 
investigated for the presence of these compounds, while in the case of Chlorella genus, retinoid-like 
activities were only ruled out for Chlorella kessleri [27]. Therefore, in the present study, we also 
assessed teratogenicity using the well-established zebrafish embryo assay [44]. As demonstrated, no 
significant or marked effects on embryo/larvae development were found for the lipophilic fractions 
obtained from food supplements. The only exception was the spinal curvature induced by two 
Chlorella samples. The causative agent remains unknown. If one considers that the majority of food 
supplements from this group did not produce such an effect, it can be postulated that it is likely due 
to the result of the low quality and potential contamination of selected products. Some Chlorella-
based supplements have been shown to contain various polycyclic aromatic hydrocarbons (PAHs) 
[45,46], and these compounds are known to induce various teratogenic effects [47]. The content of 
PAHs in microalgal supplements would, however, require a comprehensive screening. 
To further explore potential toxicities of lipophilic fractions obtained from the tested food 
supplements, their potential to induce oxidative stress, genotoxicity and neurotoxicity was also 
assessed in vivo using adult zebrafish. As demonstrated, selected samples increased the level of ROS, 
CAT activity, lipid peroxidation (as indicated by the TBARS assay) and increased frequency of DNA 
strand breaks in hepatic tissue. This indicates that these fractions possessed cytotoxic potency. The 
cytotoxicity of extracts of Chlorella and Spirulina food supplements were previously demonstrated 
in vitro in A549 cells, although none of the tested products contained detectable levels of cyanotoxins, 
such as microcystins, nodularins, saxitoxins, anatoxin-a and cylindrospermopsin [48]. Case reports 
of hepatotoxicity associated with the use of food supplements based on Chlorella and Spirulina were 
also reported [11,49,50]. All in all, this highlights that the safety of selected microalgal products is 
questionable. However, one should bear in mind that the fractions of three Spirulina supplements 
tested in the present study decreased the level of lipid peroxidation as compared to the control which 
is in line with the hepatoprotective properties of these products reported previously in vitro, in vivo 
and in clinical trials [51,52]. 
As demonstrated in the present study, 60% and 31% of fractions of Chlorella and Spirulina, 
respectively, induced an increase in cholinesterase activity in zebrafish brain homogenate. This 
indicates that these fractions could contain compounds causing a potential loss of cholinergic 
homeostasis leading to acetylcholine degradation and downregulation of acetylcholine receptors [53]. 
In turn, the exposure to 61.5% of Spirulina fractions (and one fraction of Chlorella) was associated 
with a decrease in cholinesterase activity, which may be associated with increased levels of 
acetylcholine and overstimulation of cholinergic stimulation [54]. Both an increase and decrease in 
cholinesterase activity can be associated with adverse effects, although their potential occurrence 
would require further assessment. There are no known reports of neurotoxicity following the use of 
Chlorella and Spirulina. However, the findings of the present study suggest that both groups of food 
supplements may contain lipophilic compounds possessing potential neuromodulatory activities. 
4. Conclusions 
The present study highlights that commercially available microalgal food supplements based on 
biomass of Spirulina and Chlorella are free of PMAs, while the lipophilic fractions obtained from 
most of these products do not reveal teratogenicity in a zebrafish model. However, some fractions 
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revealed cytotoxicity and neurotoxicity and affected cholinesterase activity. This indicates that the 
quality and safety of selected microalgal products may be questionable. 
5. Materials and Methods 
5.1. Food Supplements 
A total of 10 Chlorella-based and 13 Spirulina-based food supplements were randomly 
purchased from Polish online stores. The inclusion criteria were official registration as a food 
supplement, tablet or powder form and country of origin declared on the label. The general 
characteristics of the studied products and the region of origin are summarized in Table 1. 
5.2. Sample Extraction 
The whole batch of each supplement was ground and thoroughly mixed. The powdered samples 
(10 g) were suspended in CHCl3 (50 mL) and stirred vigorously for 16 h then filtered using a sintered 
filter apparatus. This procedure was repeated a total of three times and the combined extracts dried 
(MsSO4), filtered, the solvent removed under reduced pressure and the residue obtained dried under 
high vacuum to a constant weight (typically between 5% to 15% by mass of extract was obtained; see 
Supplementary Material for full details). The material obtained was fractioned using silica gel 
chromatography eluting with a stepwise gradient of 200 mL each of: 10%, 20%, 40% and 100% ethyl 
acetate in petrol. Each fraction was collected and evaporated to dryness using a rotary evaporator 
(Buchi R124 Rotavapor, Flawil, Switzerland) and the ethyl acetate fraction was typically between 
0.5% to 3.0% by mass of the original supplement (see Supplementary Material for full details). 
5.3. Mass Spectrometry 
To identify PMAs in the obtained fractions a mass spectrometry analysis was performed with 
an LTQ Orbitrap XL Mass Spectrometer (Thermo Fisher, Altrincham, UK). Initial characterization of 
samples was made by atmospheric pressure chemical ionization (APCI) mass spectrometry via an 
Atmospheric Solids Analysis Probe (ASAP) on a Waters Xevo G2-S instrument. A small amount of 
solid sample was transferred to the tip of a glass capillary, which was then placed within the ASAP 
source and inserted into the instrument. The vaporizer temperature was increased from 50 °C to a 
temperature at which ions were observed and acquired; the discharge current was 4 μA. Data was 
processed using vendor MassLynx software. Since no analytical standards were available and no 
database for these compounds exists, a comparison with literature was performed [17,18]. 
5.4. Toxicological Assays 
All zebrafish exposures were conducted at 18 ± 1 °C. Adult 6-month old zebrafish were obtained 
from a commercial supplier (Ukraine). The fish underwent an initial acclimation for 7 days and then 
were randomly distributed to the control, Spirulina (S) and Chlorella (C) exposure groups, with 3 
replicate tanks per group, and six specimens per replicate. During acclimation and experimental 
treatment, D. rerio were fed ad libitum with a commercial food. Water was changed every two days. 
For Spirulina and Chlorella exposures, a static renewal design was used with algae extract addition 
during each water change. The exposure treatment was continued for 14 days. Clear solution of 
lipophilic fractions (100%) of Spirulina and Chlorella in 2 mL 96% ethanol was added to the 
experimental tanks to a nominal concentration of 200 μL L-1 by means of dilution of stock solution of 
lipophilic fractions into 5000 times. Ethical manifestations of Institutional Animal Care and Use 
Committee protocols (The Institutional Animal Care and Use Committee of the Ternopil V. Hnatiuk 
National Pedagogical University approved experimental protocols and sampling procedures 
(approval no. 3/2019, approval date: 3 September 2019). National and international guidelines for the 
care and use of fisheries were followed. The tissues were sampled according to the Guide for the Care 
and Use of Laboratory Animals. 
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After exposure, the zebrafish were anesthetized by tricaine. Samples of hepatic tissue and 
peripheral blood from six specimens in each group were prepared individually and kept at –20 °C 
(for less than three days) until analyses. Hepatic and brain tissue was homogenized (1:10 w/v) at 4 °C 
in 0.1 M pH 7.4 phosphate buffer containing 100 mM KCl, 1 mM EDTA and 0.1 mM 
phenylmethylsulfonylfluoride. The homogenate was centrifuged at 6000× g for 10 min at 4 ° C. Protein 
concentration in the supernatant was measured according to Lowry et al. (1951) with bovine serum 
albumin as a standard. The absorbance was measured with a UV/Vis spectrophotometer, and the 
fluorescence was measured on the f-max fluorescence microplate reader (Molecular Devices, San 
Jose, CA, USA). 
5.4.1. Embryotoxicity Testing in Danio Rerio 
The embryo toxicity test was carried out using D. rerio embryos in accordance with the OECD 
[55]. In brief, adult specimens of wild-type zebrafish (older than 6 months) with high potential to lay 
fertilized eggs were chosen to spawn, and then, the standard method of breeding was used [55]. Egg 
production was from female and male spawning groups at a ratio of 1:2, correspondingly. Mating 
and spawning occurred within 30 min after turning on the lights in the morning. Egg laying was 
covered with a plastic mesh for protection against predation. Approx. 30 min after the light exposure, 
the egg traps were removed, and the eggs were collected. Following this, the eggs were rinsed in 
0.0002% methylene blue (Sigma-Aldrich, St. Louis, MO, USA), diluted in medium and placed into 
Petri dishes. Within 2 h post-fertilization healthy fertilized eggs were selected for the subsequent 
embryo toxicity test. Zebrafish embryos (n = 6) were exposed in a 24-well plate filled with 2 mL Tris-
buffer containing 0.4 μL of a lipophilic fraction (100%) of each supplement in 2 mL 96% ethanol at 26 
°C with a 12:12-h light/dark cycle. The observed endpoints within 120 h exposure included mortality, 
egg coagulation and morphological changes, among which tail and chorda malformation, spinal 
curvature, otolith and eyes were recorded. The endpoint had to be reflected in ≥50% of all embryos 
and/or larvae to indicate the teratogenic effect. 
5.4.2. Oxidative Stress Assays 
The rates of reactive oxygen species formation in the liver homogenates in 0.1 M phosphate 
buffer pH 7.4 were determined using dihydrorhodamine, which is converted by reactive oxygen 
species to the fluorescent compound rhodamine-123 [56]. The fluorescence signal was registered by 
an f-max plate-reader [excitation = 485 nm, emission = 538 nm], and the rates of reactive oxygen 
species formation were determined as the difference of the fluorescence at time 0 and after 20 min of 
incubation and expressed as relative fluorescence unite (RFU) per 1 g of liver tissue. Lipid 
peroxidation (LPO) was determined in the supernatant of the liver tissue homogenate (1:10 m/v) in 
0.1 M phosphate buffer pH 7.4 using thiobarbituric acid protocol. The level of thiobarbituric acid-
reactive substances (TBARS) was measured colorimetrically at 532 nm [57] and calculated using a 
molar extinction coefficient of 1.56 × 105 M−1·cm−1. Catalase (CAT) activity was determined in the 
supernatant of liver tissue homogenate (1:10 w:v) in 0.1 M pH 7.4 phosphate buffer by following the 
decrease in hydrogen peroxide at 240 nm [58]. CAT activity was determined using the extinction 
coefficient, ε = 40 M−1·cm−1 and expressed as mmol × min−1 × g−1 tissue. Glutathione S-transferase (GST) 
activity was measured in the D. rerio liver tissue homogenate (1:10 m/v) using 1-chloro-2,4- 
dinitrobenzene (CDNB) reduction assay [59]. GST activity was determined as the CDNB absorbance 
difference over time using an extinction coefficient of 9.6 mM−1 cm−1 and expressed as nmol g−1 tissue. 
5.4.3. Genotoxicity Assays 
To analyze the genotoxicity of lipophilic fractions isolated from Chlorella and Spirulina food 
supplements, levels of protein-free DNA strand breaks in zebrafish liver tissue homogenate were 
determined by the alkaline DNA precipitation assay [60] based on using Hoechst 33342 dye in the 
presence of 4 mM sodium cholate [61]. The fluorescence signal was detected by an f-max fluorescence 
plate-reader (excitation = 360 nm, emission = 450 nm). The amount of protein-free DNA strand breaks 
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was referred to the concentration of the protein in the sample. The genotoxic effect of model 
exposures was assessed as the micronucleated erythrocytes in the peripheral blood of adult D. rerio 
using Giemsa stain protocol [62]. The frequency of micronuclei was expressed per 1,000 cells. 
5.4.4. Neurotoxicity Assay 
Cholinesterase (ChE, EC 3.1.1.7) activity was determined in the zebrafish brain as 
acetylthiocholine-cleaving ChE activity according to the colorimetric method of Ellman et al. [63]. 
ChE activity was calculated using a molar extinction coefficient of 13.6·103 М–1·сm–1 and referred to 
the soluble protein content. 
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